Methamphetamine and MDMA (3,4-methylenedioxymethamphetamine) Induce Apoptosis in Both Human Serotonergic and Dopaminergic Cell Lines |
Kim, Kyu Bong
(Division of Safety Evaluation, National Institute of Toxicological Research, KFDA)
Suh, Soo Kyung (Division of Safety Evaluation, National Institute of Toxicological Research, KFDA) Lee, Bo Kyung (Division of Safety Evaluation, National Institute of Toxicological Research, KFDA) Kim, Byung Kyu (Division of Safety Evaluation, National Institute of Toxicological Research, KFDA) Kim, Jae Hee (Division of Safety Evaluation, National Institute of Toxicological Research, KFDA) Han, Eui Sik (Division of Safety Evaluation, National Institute of Toxicological Research, KFDA) Park, Chang Won (Division of Safety Evaluation, National Institute of Toxicological Research, KFDA) Kim, Jong Won (Division of Safety Evaluation, National Institute of Toxicological Research, KFDA) Kim, Kwang Jin (Division of Safety Evaluation, National Institute of Toxicological Research, KFDA) Lee, Sun Hee (Division of Safety Evaluation, National Institute of Toxicological Research, KFDA) |
1 | Tmam, S.Z., Itzhak, Y, Cadet, J.L., Islam, F, Slikker, W. Jr., and Ali, S.F. (2001). Methaniphetamine-induced alteration in stii-atal p53 and bc1-2 expression in mice. Mol. Brain Res. 90. 174-178 DOI ScienceOn |
2 | Insel, T.R., Battaglia, G., Johannessen, J.N., Marra, S., and Souza, EBD. (1989). 3,4-Methy1enedioxymethamphetmine ('Ecstacy') selectively destroys brain serotonin tenninaIs in Rhesus Mon keys. J. Pharmacol. Exp. Ther. 249, 713-720 |
3 | O'Shea, E., Granados, R., Esteban, B., Colado, M.L, and Green, A.R. (1998). The relationship between the degree of neurode-generation of rat brain 5-HT nerve terminals and the dose and frequency of adimnistation of MDMA (ecstacy). Neurophar-macol. 37, 919-926 DOI ScienceOn |
4 | Ricaurte, G., Bryan, G., Strauss, L., Seidcn, L., and Schuster. C. (1985). Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals. Science 229, 986-988 DOI |
5 | Baldwin, H.A., Colado, M.I., Murray, T.K., De Souza, R.J. and Green, W.J. (1993). Striatal dopamine release in vivo follow-ing neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine. Br. J. Pharmacol. 108, 590-596 DOI ScienceOn |
6 | Berger, U.V., Gu, X.F. and Aznitia, E.C. (1992). The substituted amphetamine 3,4-methy1enedioxymethamphetamine, mctham-phetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptanune release via a common mechanism blocked by fluoxetin and cocaine. Eur. J. Pharmacol. 215, 153-160 DOI ScienceOn |
7 | Giovanni, A., Liang, L.P., Hastings, T.G., and Zigmond, M.J. (1995). Estimating hydroxy radical content in rat brain using systemic and intraventhcular salicylate: impact of metham- phetamine. J. Neurochem. 64, 1819-1825 DOI ScienceOn |
8 | Davidson, C., Gow, A.J., Lee, T.H. and Ellinwood, E.H. (2001). Methamphetamine ncurotoxicily: necrotic and apoptotic mech-anisms and relevance to human abuse and treatrment. Brain Res. Reviews 36, 1-22 DOI ScienceOn |
9 | De Vito M.J. and Wagner, G.C. (1989). Methamphetaimne-induced neuronal damage: a possible role for free radicals. Neurophar-macology 28, 1145-1150 DOI |
10 | Fleckcnstein, A.E., Gibb, J.W. and Hanson, G.R. (2000). Differ-ential effects of stimulants on monoaminergic transporters: pharmacological consequences and implicadons for neurotox-icity. Eur. J. Pharmacol. 406, 1-13 DOI ScienceOn |
11 | Hirata, H.H., Ladenheim, B., Carlson, E., Epstein, C., and Cadet, J.L. (1996). Automdiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: attenuadon in CuZn-superoxide dismutase transgenic mice. Brain Res. 714, 95-103 DOI ScienceOn |
12 | Woolverton, W.L., Ricaurte, G.A., Forno, L.S., and Seiden, L.S. (1989). Long term effects of chronic methamphetaimne admin-istration in rhesus monkeys. Brain Res. 11, 73-78 |
13 | Jayanthi, S., Deng, X., Bordelon, M., McCoy, M.T, and Cadet, J.L. (2001). Methamphetamine causes differential regulation of pro-death and anti-death Bc1-2 genes in the mouse neocortex. FASEB J. 15, 1745-1752 DOI ScienceOn |
14 | Johnston, L.D., OMalley, P.M., Bachman, J.G. (2000). Monitor-ing the future national survey results on adolescent drug use:overview of the key findings, 1999 (NIH publication number00-4690) |
15 | Lemaster, J.J., Qian, T., Bradham, D.A., Brenner, W.E., Cascio, L.C., Trost, Y., Nishmura, Y, Nieminen, A.L., and Herman, B. (1999). Mitochondrial dysfunction in the pathogenesis of necrotic and apoptotic cell dcath. J. Bioenerg. Biomembr. 31. 305-319 DOI ScienceOn |
16 | Keenan, E., Gervin, M., Dorman, A., and OConnor, J.J. (1993). Psychosis and recreational use of MDMA ('Ecstacy'). Irish J. Psychol. Med. 10, 162-163 |
17 | Kleven, M.S. and Seiden, L.S. (1992). Methamphetamine-induced neurotoxicity: structure activity relationships. Ann. NY. Acad. Sci. 654, 292-301 DOI ScienceOn |
18 | Kuczenski, R., Segal, D.S., Cho, A.K. and Melega, W. (1995). Hippocampus norepinephrine, caudate dopamine and seroto nine, and behavioral responses Lo the stereoisomers of amphet-aminne and methamphetamine. J. Neurosci. 15, 1308-1317 |
19 | Leshner, A.I. (2001). Using science to counter the spread of Ecstacy abuse. NIDA Notes. 16, 3-4 |
20 | Lieberman, J.A., Kinon, B.J., and Loebel, A.D. (1990). Dopamin-ergic mechanisms in idiopathic and drug-induced psychoses. Schizophr. Bull. 16, 97-110 DOI ScienceOn |
21 | Seiden, L.S. and Vosmer, G. (1984). Formation of 6-hydroxy-dopamine in caudate nucleus of the rat brain after a single large dose of methamphetamine. Pharmacol. Biochem. Beha. 21, 29-31 DOI ScienceOn |
22 | Thiriet, N., Jayanthi, S., McCoy, M., Ladenheim, B., and Cadet, J.L. (2001). Methamphetamine increases expression of the apoptotic c-myc and L-myc genes in the mouse brain. Mol.Brain Res. 90, 202-204 DOI ScienceOn |
23 | Simantov, R. and Tauber, M. (1997). The abuse drug MDMA (Ecstacy) induces programmed death of human serotonergic cells. FASEB J. 11, 141-146 |
24 | Sprague, J.E., Everman, S.L., and Nichols, D.E. (1998). An inte-gratcd hypothesis for the serotonergic axonal loss induced by 3,4-methy1enedioxymethamphetmine. Neurotoxicol. 19, 427-441 |
25 | Stone, D.M., Johnson, M., Hanson, G.R., and Gibb, J.W. (1988). Rolc of endogenous dopamine in the central serotonergic defi-cits induced by 3,4-methy1enedioxy- methamphetmine. J. Pharmacol. Exp. Ther. 247, 79-87 |
26 | Volkow, N.D., Chang, L., Wang, G.J., Fowler, J.S., Franceschi D., Sedler, M., Gatley, S.J., Miller, E., Hitzemann, R., Ding, Y.S., and Logan, J. (2001). Loss of dopamine transporters inmethamphetamine abusers recovers with protracted absti-nence. J. Neurosci. 21, 9414-9418 |
27 | Wagner, G.C., Ricaurte, G.A., Seiden, L.S., Schuster, C.R., Miller, R.J., and Westley, J. (1980). Long-lasting depletions of stnatal dopamine and loss of dopamine uptake sites following rcpeated admimstralion of methamphetamine. Brain Res. 181.151-160 DOI ScienceOn |